Andrew Dervan

442 total citations
12 papers, 213 citations indexed

About

Andrew Dervan is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Andrew Dervan has authored 12 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Hematology. Recurrent topics in Andrew Dervan's work include Multiple Myeloma Research and Treatments (4 papers), Chemokine receptors and signaling (3 papers) and Single-cell and spatial transcriptomics (2 papers). Andrew Dervan is often cited by papers focused on Multiple Myeloma Research and Treatments (4 papers), Chemokine receptors and signaling (3 papers) and Single-cell and spatial transcriptomics (2 papers). Andrew Dervan collaborates with scholars based in United States, Switzerland and Germany. Andrew Dervan's co-authors include Christine B. Weldon, Louis Dubeau, Deborah L. Johnson, Patricia A. Deverka, Sandra Johnson, Michael P. Douglas, Chi V. Dang, Julia R. Trosman, Kathryn A. Phillips and Mason W. Freeman and has published in prestigious journals such as Blood, Nature Biotechnology and Molecular and Cellular Biology.

In The Last Decade

Andrew Dervan

12 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Dervan United States 8 85 39 34 32 30 12 213
J Fulton United Kingdom 4 88 1.0× 34 0.9× 58 1.7× 63 2.0× 26 0.9× 8 186
Haley Hunter-Zinck United States 4 49 0.6× 31 0.8× 79 2.3× 19 0.6× 4 0.1× 4 171
Philip Tsau Choong Iau Singapore 8 92 1.1× 60 1.5× 56 1.6× 51 1.6× 2 0.1× 22 247
Sara Varea Spain 7 70 0.8× 12 0.3× 10 0.3× 51 1.6× 4 0.1× 13 176
Kenneth Elder Australia 8 27 0.3× 69 1.8× 15 0.4× 108 3.4× 2 0.1× 19 230
Michal A. Miller United States 8 109 1.3× 26 0.7× 9 0.3× 102 3.2× 3 0.1× 15 298
Mariam Thomas Canada 10 91 1.1× 111 2.8× 60 1.8× 48 1.5× 17 0.6× 22 281
Sean P. Gavan United Kingdom 7 30 0.4× 34 0.9× 61 1.8× 23 0.7× 30 232
Nada A.S. Alwan Iraq 11 26 0.3× 81 2.1× 60 1.8× 264 8.3× 2 0.1× 32 397
Gabrielle Bertier France 6 36 0.4× 37 0.9× 75 2.2× 10 0.3× 14 169

Countries citing papers authored by Andrew Dervan

Since Specialization
Citations

This map shows the geographic impact of Andrew Dervan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Dervan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Dervan more than expected).

Fields of papers citing papers by Andrew Dervan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Dervan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Dervan. The network helps show where Andrew Dervan may publish in the future.

Co-authorship network of co-authors of Andrew Dervan

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Dervan. A scholar is included among the top collaborators of Andrew Dervan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Dervan. Andrew Dervan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wall, Matthew A., Serdar Turkarslan, Samuel A. Danziger, et al.. (2021). Genetic program activity delineates risk, relapse, and therapy responsiveness in multiple myeloma. npj Precision Oncology. 5(1). 60–60. 6 indexed citations
2.
Bolouri, Hamid, Mary H. Young, Joshua Beilke, et al.. (2020). Integrative network modeling reveals mechanisms underlying T cell exhaustion. Scientific Reports. 10(1). 1915–1915. 16 indexed citations
3.
Aguilar, Boris, David L. Gibbs, David J. Reiss, et al.. (2020). A generalizable data-driven multicellular model of pancreatic ductal adenocarcinoma. GigaScience. 9(7). 20 indexed citations
4.
Young, Mary H., Mark Tometsko, Jamie Cavenagh, et al.. (2018). Immune Microenvironment Analysis of Bone Marrow By Mass Cytometry and RNA Sequencing in Multiple Myeloma Patients Treated with Daratumumab and Durvalumab. Blood. 132(Supplement 1). 3296–3296. 2 indexed citations
5.
Young, Mary H., Alison Fitch, Frank Schmitz, et al.. (2018). Deep Immunoprofiling of the Bone Marrow Microenvironmental Changes Underlying the Multistep Progression of Multiple Myeloma. Blood. 132(Supplement 1). 243–243. 2 indexed citations
6.
Danziger, Samuel A., Andrew Dervan, Frank Schmitz, et al.. (2017). Deconvolution of the Immune Microenvironment Can Predict the Outcome of Myeloma Patients and Inform Potential Intervention Strategies. Blood. 130. 1751–1751. 1 indexed citations
7.
Phillips, Kathryn A., Patricia A. Deverka, Julia R. Trosman, et al.. (2017). Payer coverage policies for multigene tests. Nature Biotechnology. 35(7). 614–617. 36 indexed citations
8.
Dervan, Andrew, Patricia A. Deverka, Julia R. Trosman, et al.. (2016). Payer decision making for next-generation sequencing–based genetic tests: insights from cell-free DNA prenatal screening. Genetics in Medicine. 19(5). 559–567. 20 indexed citations
9.
Freeman, Mason W. & Andrew Dervan. (2011). The Path from Bench to Bedside: Considerations before Starting the Journey. Journal of Investigative Medicine. 59(5). 746–751. 12 indexed citations
10.
Poon, Eric G., et al.. (2008). Impact of Barcode Medication Administration Technology on How Nurses Spend Their Time Providing Patient Care. JONA The Journal of Nursing Administration. 38(12). 541–549. 22 indexed citations
11.
Poon, Eric G., Carol Keohane, Andrew Dervan, et al.. (2006). Impact of barcode medication administration technology on how nurses spend their time on clinical care.. PubMed. 1065–1065. 21 indexed citations
12.
Johnson, Sandra, et al.. (2003). Increased Expression of TATA-Binding Protein, the Central Transcription Factor, Can Contribute to Oncogenesis. Molecular and Cellular Biology. 23(9). 3043–3051. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J Fulton Breakdown of academic impact, for papers by Haley Hunter-Zinck Breakdown of academic impact, for papers by Philip Tsau Choong Iau Breakdown of academic impact, for papers by Sara Varea Breakdown of academic impact, for papers by Kenneth Elder Breakdown of academic impact, for papers by Michal A. Miller Breakdown of academic impact, for papers by Mariam Thomas Breakdown of academic impact, for papers by Sean P. Gavan Breakdown of academic impact, for papers by Nada A.S. Alwan Breakdown of academic impact, for papers by Gabrielle Bertier
Rankless by CCL
2026